Jasper Therapeutics, Inc. (NASDAQ:JSPR) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of non-voting convertible preferred stock Closed: US$132M raised · Piper Sandler & Co. +1 Dealers: Piper Sandler & Co. (lead), LifeSci Capital LLC (co-lead) Buyers: Affinity Asset Advisors, LLC (co-led the private placement); Ikarian Capital LLC (co-led the private placement); Columbia Threadneedle Investments; Sirenia Capital Management LP; Brahma Capital; Balyasny Asset Management; SilverArc Capital; Squadron Capital Management; Nazare Partners LP; Mirador Therapeutics Use of proceeds: Fund development of the combined company's pipeline through the second half of 2028 | Aug 17, 2026 |
| Public offering of common stock and warrants Closed: US$30M raised · US$2.43 a share · Warrants at US$2.92 for 48 months · TD Cowen Dealers: TD Cowen (lead) Use of proceeds: Extends cash runway through the first half of 2026 | Nov 10, 2025 |